Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears
Primary Purpose
Dry Eye
Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Artificial tears
Sponsored by
About this trial
This is an interventional treatment trial for Dry Eye focused on measuring dry eye, artificial tears, tear osmolarity, residence time
Eligibility Criteria
Inclusion Criteria:
- At least 18 years of age Normal vision in both eyes (20/30 best corrected) Preference for patient with dry eye symptoms
Exclusion Criteria:
- No ocular disease other than dry eye Currently taking no ocular or systemic medications that might affect results
Sites / Locations
- Northeastern State University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Isotonic hyaluronate artificial tear
Normal saline
Arm Description
At random, subjects will receive isotonic hyaluronate artificial tear or a control (normal saline).
Outcomes
Primary Outcome Measures
Osmolarity Change From Baseline (mOsms/L) as a Function of Time (Minutes)
Raw data: Baseline (pre-instillation) tear osmolarity was measured for right and left eyes for each subject. Then measurements were repeated at 7 times (5, 20, 35, 50, 65 890 and 95 minutes) after instillation. Data processing: 1) Baseline osmolarity was subtracted from each post-baseline measurement to give a change-from-baseline values. 2) Right and left eye change values averaged to give a mean osmolarity change for each subject at each of the seven times. 3) Mean osmolarity changes values were averaged across 8 subjects for each of the 7 times and entered in the table below. Row 1 is for Drop A (hyaluronate); Row 2 for Drop B (saline). Column are for the 7 times.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01614847
Brief Title
Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears
Official Title
Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears
Study Type
Interventional
2. Study Status
Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
June 2012 (undefined)
Primary Completion Date
August 2012 (Actual)
Study Completion Date
August 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Thomas O Salmon, OD, PhD
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Background:
Osmolarity is defined as the concentration of particles dissolved in a solution. Normal tears contain various dissolved particles including proteins, salts and other electrolytes. The investigators plan to investigate how osmolarity of the tear film changes over time after instillation of artificial tears containing hyaluronate. This is one kind of artificial tear that is used to treat dry eye.
Dry eye and tear osmolarity:
Dry eye is a significant health problem, but diagnosis and treatment are often ambiguous and ineffective. There has been a resurgence of interest and research in dry eye in the past 5 years, and tear osmolarity has emerged as perhaps, one of the most effective ways to evaluate tear quality and dry eye status. Dry eye is usually treated with artificial tears, and many formulations are available. The investigators will test an isotonic solution that contains hyaluronate. Hyaluronate binds water and should help to maintain water on the eye.
Objective:
We plan to study the time course of possible changes in tear film osmolarity following instillation of an isotonic artificial tear containing hyaluronate. The investigators will use the TearLab, a new clinical instrument that has been developed to quickly and easily measure tear film osmolarity. Understanding how artificial tears affect tear film osmolarity over time can help doctors determine efficacy and dosing schedules. The investigators will test the isotonic hyaluronate (Blink Contacts) artificial tears relative to normal saline solution.
Hypothesis:
The investigators should be able to measure a decrease in tear osmolarity over time following instillation due to the water-binding effect of hyaluronate artificial tears relative to a control (normal saline solution).
Detailed Description
ABSTRACT:
Introduction: Tear hyper-osmolarity may be a fundamental cause of dry eye in many cases. Hyaluronate is an agent used in some artificial tears, which binds water and can protect against evaporation. It may therefore be an effective treatment for tear hyper-osmolarity.
Purpose: Our purpose was to measure changes in tear osmolarity over time following instillation of Blink Contacts, an isotonic ocular lubricant containing hyaluronate. We hypothesized that even in isotonic solution, the water-binding properties of hyaluronate would reduce tear osmolarity. This will help us better understand efficacy of this treatment and develop a rational basis for dosing schedules.
Methods: After baseline osmolarity measurements, eight subjects received either Blink Contacts or normal saline drops in both eyes. We re-measured osmolarity five minutes later, and then at 15-minute intervals up to 95 minutes. Subjects also rated comfort at each time. The next day, the experiment was repeated with the alternate drops for each subject.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dry Eye
Keywords
dry eye, artificial tears, tear osmolarity, residence time
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
8 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Isotonic hyaluronate artificial tear
Arm Type
Experimental
Arm Description
At random, subjects will receive isotonic hyaluronate artificial tear or a control (normal saline).
Arm Title
Normal saline
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
Artificial tears
Intervention Description
At random, subjects will receive isotonic artificial tear or a control (normal saline).
Primary Outcome Measure Information:
Title
Osmolarity Change From Baseline (mOsms/L) as a Function of Time (Minutes)
Description
Raw data: Baseline (pre-instillation) tear osmolarity was measured for right and left eyes for each subject. Then measurements were repeated at 7 times (5, 20, 35, 50, 65 890 and 95 minutes) after instillation. Data processing: 1) Baseline osmolarity was subtracted from each post-baseline measurement to give a change-from-baseline values. 2) Right and left eye change values averaged to give a mean osmolarity change for each subject at each of the seven times. 3) Mean osmolarity changes values were averaged across 8 subjects for each of the 7 times and entered in the table below. Row 1 is for Drop A (hyaluronate); Row 2 for Drop B (saline). Column are for the 7 times.
Time Frame
Baseline, followed by 7 measurements made after instillation (5, 20, 35, 50, 65, 80, 95 minutes post-instillation).
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
At least 18 years of age Normal vision in both eyes (20/30 best corrected) Preference for patient with dry eye symptoms
Exclusion Criteria:
No ocular disease other than dry eye Currently taking no ocular or systemic medications that might affect results
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas O Salmon, OD, PhD
Organizational Affiliation
Northeastern State University
Official's Role
Study Director
Facility Information:
Facility Name
Northeastern State University
City
Tahlequah
State/Province
Oklahoma
ZIP/Postal Code
74464
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears
We'll reach out to this number within 24 hrs